Opportunities and Challenges in Translating Cell and Gene Therapy Products

This workshop focuses on the rapidly evolving and complex advanced therapeutics and medicinal products (ATMP) field. ATMPs encompass a wide range of therapies, from gene and cell therapies to gene editing technology. While there has been exciting progress in the preclinical and clinical stages in recent years, this success does not necessarily equal commercial success.

This workshop brings together different perspectives from academic, industry, and regulatory fields to discuss and clarify the main issues confronting ATMP development, and offers a broad overview of the challenges of developing ATMP therapies. Topics will include adoption challenges, clinical provisions, supply chains, manufacturing and health economics.

Join us to hear and discuss the latest in the discovery and early development breakthroughs and case studies on:

• Gene editing technology
• Innovation in manufacturing
• Product testing and quality control
• Diversity in disease
• Perspectiveson clinical opportunities